News

Immunosuppression appears to reduce mortality among people with systemic sclerosis with pulmonary arterial hypertension but ...
Artificial intelligence (AI) is shaping the future of health care, offering new tools for earlier diagnosis of disease and more precise tracking of treatment outcomes. In a new Yale-led study, ...
PATIENTS with systemic sclerosis (SSc) who test positive for high levels of anti-muscarinic 3 receptor (anti-M3R) antibodies may face a more severe clinical course, particularly involving ...
April 17, 2025 /PRNewswire/ -- Biostate AI, a leading innovator in artificial intelligence for RNA sequencing ... outcomes for people with multiple sclerosis (MS). The partnership aims to develop ...
Multiple sclerosis (MS) is a chronic ... CLARITY was a randomised double-blind study of 1,326 people with active and highly active RRMS. It compared 3.5 mg/kg and 5.25 mg/kg doses of cladribine with ...
This important work advances our understanding of the aging trajectory and heterogeneity of hippocampal microglia. The authors provide an in-depth characterization of microglia in young and old mice ...
Systemic sclerosis, or scleroderma, causes the hardening of skin and connective tissues. Often, the disease harms other organs, such as the heart, kidneys, lungs, and gastrointestinal tract ...
She was told she had systemic sclerosis scleroderma and had as little ... which advocates on behalf of the 3.5million people living with rare diseases in the UK. “In many ways I’ve been ...